Stay updated on UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial

Sign up to get notified when there's something new on the UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1.0%
    Check dated 2025-04-16T09:56:50.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-09T04:55:17.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page has updated its status from 'Recruiting' to 'Active, not recruiting' and has changed the date from '2025-03-13' to '2025-03-25'.
    Difference
    1.0%
    Check dated 2025-03-25T13:19:03.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The date on the webpage has been updated from February 11, 2025, to March 13, 2025.
    Difference
    0.7%
    Check dated 2025-03-18T05:59:37.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T20:11:49.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The page has updated the study title to 'Phase 1 Study of UniCAR02-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies' and added a new date of '2025-02-11', while removing the previous trial title and date of 'Dose-escalating Trial With UniCAR02-T Cells and CD123 Target Module (TM123) in Patients With Hematologic and Lymphatic Malignancies' and '2024-05-30'.
    Difference
    4%
    Check dated 2025-02-17T13:36:14.000Z thumbnail image

Stay in the know with updates to UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial

Enter your email address, and we'll notify you when there's something new on the UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial page.